Crexendo R&D Spending Growth & History (CXDO)
Crexendo's r&d spending was $5.7M for fiscal 2025.
View full Crexendo company overviewCrexendo annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.7M | $168,000 | +3.03% |
| 2024 | 2024-12-31 | $5.6M | $692,000 | +14.24% |
| 2023 | 2023-12-31 | $4.9M | $905,000 | +22.88% |
| 2022 | 2022-12-31 | $4.0M | $2.6M | +183.31% |
| 2021 | 2021-12-31 | $1.4M | $207,000 | +17.41% |
| 2020 | 2020-12-31 | $1.2M | $336,000 | +39.39% |
| 2019 | 2019-12-31 | $853,000 | $52,000 | +6.49% |
| 2018 | 2018-12-31 | $801,000 | $51,000 | +6.80% |
| 2017 | 2017-12-31 | $750,000 | −$76,000 | −9.20% |
| 2016 | 2016-12-31 | $826,000 | $47,000 | +6.03% |
| 2015 | 2015-12-31 | $779,000 | −$825,000 | −51.43% |
| 2014 | 2014-12-31 | $1.6M | −$88,000 | −5.20% |
| 2013 | 2013-12-31 | $1.7M | −$293,000 | −14.76% |
| 2012 | 2012-12-31 | $2.0M | −$1.3M | −39.15% |
| 2011 | 2011-12-31 | $3.3M | $172,000 | +5.57% |
| 2010 | 2010-12-31 | $3.1M | — | — |
Crexendo quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.8M | $393,000 | +27.35% |
| Q1 2026 | 2026-03-31 | $1.6M | $44,000 | +2.89% |
| Q4 2025 | 2025-12-31 | $1.3M | −$156,000 | −10.39% |
| Q3 2025 | 2025-09-30 | $1.4M | −$59,000 | −4.01% |
| Q2 2025 | 2025-06-30 | $1.4M | $109,000 | +8.21% |
| Q1 2025 | 2025-03-31 | $1.5M | $274,000 | +21.94% |
| Q4 2024 | 2024-12-31 | $1.5M | $247,000 | +19.68% |
| Q3 2024 | 2024-09-30 | $1.5M | $198,000 | +15.53% |
| Q2 2024 | 2024-06-30 | $1.3M | $190,000 | +16.70% |
| Q1 2024 | 2024-03-31 | $1.2M | $58,000 | +4.87% |
| Q4 2023 | 2023-12-31 | $1.3M | −$16,000 | −1.26% |
| Q3 2023 | 2023-09-30 | $1.3M | $124,000 | +10.77% |
| Q2 2023 | 2023-06-30 | $1.1M | −$91,000 | −7.40% |
| Q1 2023 | 2023-03-31 | $1.2M | $887,000 | +291.78% |
| Q4 2022 | 2022-12-31 | $1.3M | $971,000 | +323.67% |
| Q3 2022 | 2022-09-30 | $1.2M | $793,000 | +221.51% |
| Q2 2022 | 2022-06-30 | $1.2M | $841,000 | +216.75% |
| Q1 2022 | 2022-03-31 | $304,000 | −$46,000 | −13.14% |
| Q4 2021 | 2021-12-31 | $300,000 | −$49,000 | −14.04% |
| Q3 2021 | 2021-09-30 | $358,000 | $32,000 | +9.82% |
| Q2 2021 | 2021-06-30 | $388,000 | $144,000 | +59.02% |
| Q1 2021 | 2021-03-31 | $350,000 | $80,000 | +29.63% |
| Q4 2020 | 2020-12-31 | $349,000 | $120,000 | +52.40% |
| Q3 2020 | 2020-09-30 | $326,000 | $111,000 | +51.63% |
| Q2 2020 | 2020-06-30 | $244,000 | $47,000 | +23.86% |
| Q1 2020 | 2020-03-31 | $270,000 | $58,000 | +27.36% |
| Q4 2019 | 2019-12-31 | $229,000 | $17,000 | +8.02% |
| Q3 2019 | 2019-09-30 | $215,000 | $1,000 | +0.47% |
| Q2 2019 | 2019-06-30 | $197,000 | $3,000 | +1.55% |
| Q1 2019 | 2019-03-31 | $212,000 | $31,000 | +17.13% |
| Q4 2018 | 2018-12-31 | $212,000 | $31,000 | +17.13% |
| Q3 2018 | 2018-09-30 | $214,000 | $20,000 | +10.31% |
| Q2 2018 | 2018-06-30 | $194,000 | $9,000 | +4.86% |
| Q1 2018 | 2018-03-31 | $181,000 | −$9,000 | −4.74% |
| Q4 2017 | 2017-12-31 | $181,000 | −$11,000 | −5.73% |
| Q3 2017 | 2017-09-30 | $194,000 | $5,000 | +2.65% |
| Q2 2017 | 2017-06-30 | $185,000 | −$31,000 | −14.35% |
| Q1 2017 | 2017-03-31 | $190,000 | −$39,000 | −17.03% |
| Q4 2016 | 2016-12-31 | $192,000 | −$10,000 | −4.95% |
| Q3 2016 | 2016-09-30 | $189,000 | −$20,000 | −9.57% |
| Q2 2016 | 2016-06-30 | $216,000 | $51,000 | +30.91% |
| Q1 2016 | 2016-03-31 | $229,000 | $26,000 | +12.81% |
| Q4 2015 | 2015-12-31 | $202,000 | −$159,000 | −44.04% |
| Q3 2015 | 2015-09-30 | $209,000 | −$185,000 | −46.95% |
| Q2 2015 | 2015-06-30 | $165,000 | −$270,000 | −62.07% |
| Q1 2015 | 2015-03-31 | $203,000 | −$211,000 | −50.97% |
| Q4 2014 | 2014-12-31 | $361,000 | −$40,000 | −9.98% |
| Q3 2014 | 2014-09-30 | $394,000 | −$2,000 | −0.51% |
| Q2 2014 | 2014-06-30 | $435,000 | $21,000 | +5.07% |
| Q1 2014 | 2014-03-31 | $414,000 | −$67,000 | −13.93% |
| Q4 2013 | 2013-12-31 | $401,000 | −$65,000 | −13.95% |
| Q3 2013 | 2013-09-30 | $396,000 | −$24,000 | −5.71% |
| Q2 2013 | 2013-06-30 | $414,000 | −$91,000 | −18.02% |
| Q1 2013 | 2013-03-31 | $481,000 | −$113,000 | −19.02% |
| Q4 2012 | 2012-12-31 | $466,000 | −$246,000 | −34.55% |
| Q3 2012 | 2012-09-30 | $420,000 | −$387,000 | −47.96% |
| Q2 2012 | 2012-06-30 | $505,000 | −$366,000 | −42.02% |
| Q1 2012 | 2012-03-31 | $594,000 | −$278,000 | −31.88% |
| Q4 2011 | 2011-12-31 | $712,000 | −$168,000 | −19.09% |
| Q3 2011 | 2011-09-30 | $807,000 | −$150,000 | −15.67% |
| Q2 2011 | 2011-06-30 | $871,000 | $156,000 | +21.82% |
| Q1 2011 | 2011-03-31 | $872,000 | $334,000 | +62.08% |
| Q4 2010 | 2010-12-31 | $880,000 | — | — |
| Q3 2010 | 2010-09-30 | $957,000 | — | — |
| Q2 2010 | 2010-06-30 | $715,000 | — | — |
| Q1 2010 | 2010-03-31 | $538,000 | — | — |
Crexendo r&d spending trends
Over the last five fiscal years, Crexendo's r&d spending increased from $1.2M to $5.7M, a change of $4.5M. The latest reported quarter, Q2 2026, shows $1.8M.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Crexendo source filings ↗